Another 8x Risk to Reward Stock (SBFM)

18 apr 2024

SBFM

About
Sunshine Biopharma, Inc. is a New York-based pharmaceutical company that develops and commercializes oncology and antiviral drugs, as well as science-based nutritional supplements. Their products include treatments for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006.


Recent News
Stock Split April 17th, 2024

5 Point Inspection by OnePunchman:

1. Free Float shares‪‪: 953.39 K‬‬ - Positive
   
2. Cash & equivalents: 16.29 M‬‬ - Positive
   
3. Debt: 657.71 K‬‬ - Positive
   
4. Last Quarter Revenue:7.68M - Positive compared to Cash in hand and Free Float
   
5. Prescriptions Drugs are in the market - https://sunshinebiopharma.com/prescription-drugs/
   

Buy Alert done by Fibonacci retracement levels:
Price: $3.20

• Entire Position Stop Loss: $2.91
  
• 1st Take Profit: $5.30 (I would sell 50% of my holdings here) - Risk to Reward Ratio is x8
  
• 2nd Take Profit: $8.79 (I would sell 30% of my holdings here) - Risk to Reward Ratio is x21
  
• 3rd Take Profit: $10.25 (I would sell 20% of my remaining holdings here) - Risk to Reward Ratio is x27
  

19 apr 2024

Trade chiuso: stop raggiunto